Alveolar macrophage response to remote organ injury

Shock

Volumn 9, Issue 4, 1998, Pages 261-265

  LaNoue, John L ^a,b   Iglesias, José L ^a,b   Rogers, Thomas E ^a,b   Kim, Lawrence T ^c   Meng, Yan ^c   Myers, Stuart I ^c   Turnage, Richard H ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; PROSTAGLANDIN E2; SUPEROXIDE; THROMBOXANE B2;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD CLOTTING; CELL CULTURE; ENZYMOLOGY; IMMUNOLOGY; INTESTINE; ISCHEMIA; LUNG ALVEOLUS MACROPHAGE; LUNG EDEMA; LYSOSOME; MACROPHAGE ACTIVATION; MALE; MESENTERIC ARTERY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; BLOOD COAGULATION; CELLS, CULTURED; DINOPROSTONE; GLUCURONIDASE; INTESTINES; ISCHEMIA; LYSOSOMES; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MALE; MESENTERIC ARTERIES; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPEROXIDES; THROMBOXANE B2;

EID: 0032040313     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199804000-00005     Document Type: Article

References (39)

1. 2 mediates increase pulmonary microvascular permeability after intestinal reperfusion. J Appl Physiol 82:592-598, 1997.
2. Schmeling DJ, Caty MG, Oldham KT, Guice KS, Hinshaw DB: Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion. Surgery 106:195-202, 1989
3. Turnage RH, Magee JC, Guice CS, Myers SI, Oldham KT: Complement activation by the hydroxyl radical during intestinal reperfusion. Shock 2(6):445-450, 1994.
4. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI: Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion. Ann Surg 218:444-453, 1993.
5. Welborn MB 3rd, Douglas WG, Abouhamze Z, et al: Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse. Shock 6:171-176, 1996.
6. Carter MB, Wilson MA, Wead WB, Garrison RN: Platelet-activating factor mediators pulmonary macromolecular leak following intestinal ischemia-reperfusion. J Surg Res 60:403-408, 1996.
7. Koike K, Moore FA, Moore EE, Read RA, Carl VS, Banerjee A: Gut ischemia mediates lung injury by a xanthine oxidase-dependent neutrophil mechanism. J Surg Res 54:469-473, 1993.
8. Terada LS, Dormish JJ, Shanley PF, Leff JA, Anderson BO, Repine JE: Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. Am J Physiol 263:L394-L401, 1992.
9. Maier RV, Hahnel GB, Pohlman TH: Endotoxin requirements for alveolar macrophage stimulation. J Trauma 30:S49-S57, 1990.
10. Turnage RH, Kadesky KM, Bartula L, Myers SI: Intestinal reperfusion up-regulates inducible nitric oxide synthase activity within the lung. Surgery 118:288-293, 1995.
11. DeCastro CMMB, Burear MF, Nahori MA, Dumarey CH, Vargaftig BB, Bachelet M: Modulation by dexamethasone of phospholipase A2 activities in endotoxemic guinea pigs. J Appl Physiol 79:1271-1277, 1995.
12. Turnage RH, Guice KS, Oldham KT: Endotoxemia and remote organ injury following intestinal reperfusion. J Surg Res 56:571-578, 1994.
13. Turnage RH, Bagnasco J, Berger J, Guice KS, Oldham KT, Hinshaw DB: Hepatocellular oxidant stress following intestinal ischemia-reperfusion injury. J Surg Res 51:467-471, 1990.
14. Maier RV, Hahnel GB: Is macrophage-induced microthrombosis during endotoxemia dependent on prostaglandin synthesis? J Surg Res 40:238-247, 1986.
15. Goya T, Abe M, Shimura H, Torisu M: Characteristics of alveolar macrophages in experimental septic lung. J Leukoc Biol 52:236-243, 1992.
16. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254:1976.
17. nd ed. New York: Ravin Press, 1992, pp 637-662.
18. Coquette A, Bowynaems JM, Saint-Guillain M, Vray B: Macrophage heterogeneity in prostaglandins and thromboxane synthesis: Differential activation by Fc- and C3b-dependent bacterial phagocytosis. Prostaglandins 36:491-505, 1981.
19. Hsueh W, Arroyave CM, Jordan RL: Identification of C3b as the major serum protein that stimulates prostaglandin and thromboxane synthesis by macrophages. Prostaglandins 28:889-994, 1984.
20. Tripp CS, Leahy KM, Needleman P: Thromboxane synthase is preferentially conserved in activated mouse peritoneal macrophages. J Clin Invest 76:898-901, 1985.
21. Goerig M, Habenicht AJR, Heitz R, et al: Sn-1,2-diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells. J Clin Invest 79:903-911, 1987.
22. Nusing R, Goerig M, Habenicht AJR, Ullrich V: Selective eicosanoid formation during HL-60 macrophage differentiation: Regulation of thromboxane synthase. Eur J Biochem 212:371-376, 1993.
23. Hamilton TA, Adams DO: Molecular mechanisms of signal transduction in macrophages. Immunol Today 8:151-158, 1987.
24. Kato M, Tokuyama K, Morikawa A, Kuroume T, Barnes PJ: Platelet-activating factor-induced enhancement of superoxide anion generation in guinea pigs. Eur J Pharmacol 232:7-12, 1993.
25. Rouis M, Nigon F, Chapman J: Platelet-activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages. Biochem Biophys Res Commun 156:1293-1301, 1988.
26. Das UN, Ells G, Begin ME, Horrobin DF: Free radicals as possible mediators of the actions of interferon. J Free Radicals in Biology & Medicine 2:183-188, 1986.
27. Lohmann-Matthes, M-L, Steinmuller C, Franke-Ullman G: Pulmonary macrophages. Eur Respir J 7:1678-1689, 1994.
28. Kadesky KM, Turnage RH, Roger TE, Inman L, Myers SI: In vitro evidence of neutrophil-mediated lung injury after intestinal reperfusion. Shock 4:102-106, 1995.
29. Tate RM, Vanbenthuysen DM, Shasby DM, McMurtry IF, Repine JE: Oxygen-radical-mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs. Am Rev Respir Dis 126:802-806, 1982.
30. Goldman G, Welbourn R, Kobzik L, Valeri CR, Shepro D, Hechtman HB: Reactive oxygen species and elastase mediate lung permeability after acid aspiration. J Appl Physiol 73:571-575, 1992.
31. 2 inhibition decouples lung injury from gut ischemia-reperfusion. Surgery 112:173-180, 1992.
32. Royall JA, Kooy NW, Beckman JS: Nitric oxide-related oxidants in acute lung injury. New Horizons 3:113-122, 1995.
33. Well S, James KK, Levin EG, et al: Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 84:695-705, 1989.
34. 2 mediates increased pulmonary microvascular permeability following limb ischemia. Circ Res 64:1178-1189, 1989.
35. Zamora CA, Baron DA, Heffner JE: Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury. J Appl Physiol 74:224-229, 1993.
36. Welles SL, Shepro D, Hechtman HB: Eicosanoids modulation of stress fibers in cultured bovine endothelial cells. Inflammation 9:439-450, 1985.
37. Shasby DM, Shasby SS, Sullivan JM, Peach MJ: Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ Res 51:657-661, 1982.
38. Seale JP, Nourshargh S, Hellewell PG, Williams TJ: Mechanism of action of platelet activating factor in the pulmonary circulation: An investigation using a novel isotopic system in rabbit isolated lung. Br J Pharmacol 104:251-257, 1991.
39. Olson NC, Joyce PB, Fleisher LN: Role of platelet activating factor and eicosanoids during endotoxin-induced lung injury in pigs. Am J Physiol 258:H1674-H1686, 1990.